Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 408-417

  Calbo, Sébastien ^a,b,d   Delagrèverie, Héloïse ^a,b   Arnoult, Christophe ^a,b   Authier, François Jérome ^c   Tron, François ^a,b   Boyer, Olivier ^a,b,d  

^a Institute for Biomedical Research   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PROGRAMMED DEATH 1 PROTEIN; REGULATOR PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ANTIGEN; DIFFERENTIATION ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; PD 1 ANTIGEN, MOUSE; PD-1 ANTIGEN, MOUSE;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CLONAL ANERGY; CYTOTOXICITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKELETAL MUSCLE; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHICKEN; GENE EXPRESSION; GENETICS; IMMUNOLOGY; TRANSGENE;

ANIMALS; ANTIGENS; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHICKENS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; TRANSGENES; UP-REGULATION;

EID: 47949091729     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.408     Document Type: Article

References (67)

1. Kappler, J. W., N. Roehm, and P. Manack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280.
2. + thymocytes. Nature 333: 742-746.
3. Derbinski, J., J. Gäbler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. Peltonen, J. Walter, and B. Kyewski. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202: 33-45.
4. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305-317.
5. Gershon, R. K., P. Cohen, R. Hencin, and S. A. Liebhaber. 1972. Suppressor T cells. J. Immunol. 108: 586-590.
6. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
7. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells': clonal elimination as a consequence of immunity. Cell 63: 1249-1256.
8. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-761.
9. Burkly, L. C., D. Lo, O. Kanagawa, R. L. Brinster, and R. A. Flavell. 1989. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature 342: 564-566.
10. Singer, D. S., E. Mozes, S. Kirshner, and L. D. Kohn. 1997. Role of MHC class I molecules in autoimmune disease. Crit. Rev. Immunol. 17: 463-468.
11. Karpati, G., Y. Pouliot, and S. Carpenter. 1988. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann. Neurol. 23: 64-72.
12. Pavlath, G. K. 2002. Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis. J. Neuroimmunol. 125: 42-50.
13. Nagaraju, K., N. Raben, L. Loeffler, T. Parker, P. J. Rochon, E. Lee, C. Danning, R. Wada, C. Thompson, G. Bahtiyar, et al. 2000. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myosilis and myositis-specific autoantibodies. Proc. Natl. Acad. Sci. USA 97: 9209-9214.
14. Jain, A., M. C. Sharma, C. Sarkar, R. Bhatia, S. Singh, and R. Handa. 2007. Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies. Arch Pathol. Lab. Med. 131: 1070-1076.
15. Bottazzo, G. F., B. M. Dean, J. M. McNally, E. H. MacKay, P. G. Swift, and D. R. Gamble. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313: 353-360.
16. Briani, C., A. Doria, P. Sarzi-Puttini, and M. C. Dalakas. 2006. Update on idiopathic inflammatory myopathies. Autoimmunity 39: 161-170.
17. Emslie-Smith, A. M., K. Arahata, and A. G. Engel. 1989. Major histocompatibility complex class I antigen expression, immunolocalizalion of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20: 224-231.
18. Li, C. K., H. Varsani, J. L. Holton, B. Gao, P. Woo, and L. R. Wedderbum. 2004. MHC Class I overexpression on muscles in early juvenile dermatomyositis. J. Rheumatol. 31: 605-609.
19. + T cells. J. Exp. Med. 181: 1863-1868.
20. Benveniste, O., P. Cherin, T. Maisonobe, R. Merat, O. Chosidow, L. Mouthon, L. Guillevin, A. Flahault, M. C. Burland, D. Klatzmann, el al. 2001. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J. Immunol. 167: 3521-3529.
21. Conti-Fine, B. M., M. Milani, and H. J. Kaminski. 2006. Myasthenia gravis: past, present, and future. J. Clin. Invest. 116: 2843-2854.
22. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
23. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
24. Ehst, B. D., E. Ingulli, and M. K. Jenkins. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CDS T cells during graft rejection. Am. J. Transplant. 3: 1355-1362.
25. Reisz-Porszasz, S., S. Bhasin, J. N. Artaza, R. Shen, I. Sinha-Hikim, A. Hogue, T. J. Fielder, and N. F. Gonzalez-Cadavid. 2003. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am. J. Physiol. Endocrinol. Metab. 285: E876-E888.
26. + phagocytes. J. Exp. Med. 204: 2075-2087.
27. Zhou, F., B. T. Rouse, and L. Huang. 1992. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in lipo-somes: a model study. Cancer Res. 52: 6287-6291.
28. Larochelle, N., H. Lochmuller, J. Zhao, A. Jani, P. Hallauer, K. E. Hastings, B. Massie, S. Prescott, B. J. Petrof, G. Karpati, and J. Nalbantoglu. 1997. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer. Gene Ther. 4: 465-472.
29. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H. P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76: 651-663.
30. Pimorady-Esfahani, A., M. D. Grounds, and P. G. McMenamin. 1997. Macro-phages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve. 20: 158-166.
31. Bonasio, R., M. L. Scimone, P. Schaerli, N. Grabie, A. H. Lichtman, and U. H. von Andrian. 2006. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7: 1092-1100.
32. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7: 255-271.
33. Kurts, C., W. R. Heath, F. R. Carbone, J. Allison, J. F. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184: 923-930.
34. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
35. Mueller, D. L., and M. K. Jenkins. 1995. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7: 375-381.
36. Black, C. A. 1999. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5: 7-9.
37. + T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens. J. Immunol. 143: 4287-4291.
38. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184: 387-396.
39. Kretschmer, K., I. Apostolou, E. Jaeckel, K. Khazaie, and H. von Boehmer. 2006. Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol. Rev. 212: 163-169.
40. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
41. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199: 1401-1408.
42. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
43. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
44. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
45. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
46. Welsh, R. M. 2001. Assessing CD8 T cell number and dysfunction in the presence of antigen. J. Exp. Med. 193: F19-F22.
47. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
48. Shin, H., and E. J. Wherry. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19: 408-415.
49. Kurts, C., R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. Miller, and W. R. Heath. 1999. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 96: 12703-12707.
50. Stacy, S., B. E. Gelb, B. A. Koop, J. J. Windle, K. A. Wall, K. A. Krolick, A. J. Infante, and E. Kraig. 2002. Split tolerance in a novel transgenic model of autoimmune myasthenia gravis. J. Immunol. 169: 6570-6579.
51. Salmon, A. M., C. Bruand, A. Cardona, J. P. Changeux, and S. Berrih-Aknin. 1998. An acetylcholine receptor α subunit promoter confers intrathymic expression in transgenic mice: implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. J. Clin. Invest. 101: 2340-2350.
52. Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, and T. Honjo. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319-322.
53. Okazaki, T., Y. Tanaka, R. Nishio, T. Mitsuiye, A. Mizoguchi, J. Wang, M. Ishida, H. Hiai, A. Matsumori, N. Minato, and T. Honjo. 2003. Autoantibod-ies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-I-deficient mice. Nat. Med. 9: 1477-1483.
54. + T-cell mediated injury in the heart. Circulation 116: 2062-2071.
55. Wiendl, H., M. Mitsdoerffer, D. Schneider, L. Chen, H. Lochmuller, A. Melms, and M. Weller. 2003. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J. 17: 1892-1894.
56. Guleria, I., A. Khosroshahi, M. J. Ansari, A. Habicht, M. Azuma, H. Yagita, R. J. Noelle, A. Coyle, A. L. Mellor, S. J. Khoury, and M. H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomatemal tolerance. J. Exp. Med. 202: 231-237.
57. Hori, J., M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma. 2006. B7-Hl-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177: 5928-5935.
58. + T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Invest. Ophthalmol. Vis. Sci. 47: 4444-4452.
59. + T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179: 5064-5070.
60. Goldberg, M. V., C. H. Maris, E. L. Hipkiss, A. S. Hies, L. Zhen, R. M. Tuder, J. F. Grosso, T. J. Harris, D. Getnet, K. A. Whartenby, et al. 2007. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 110: 186-192.
61. + T cell tolerance to tissue antigens. J. Immunol. 177: 8291-8295.
62. Shen, L., and K. L. Rock. 2006. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr. Opin. Immunol. 18: 85-91.
63. Authier, F. J., B. Chazaud, A. Plonquet, M. C. Eliezer-Vanerot, F. Poron, L. Belec, G. Barlovatz-Meimon, and R. K. Gherardi. 1999. Differential expression of the IL-1 system components during in vitro myogenesis: implication of IL-1β in induction of myogenic cell apoptosis. Cell Death Differ. 6: 1012-1021.
64. Arnold, B., T. Schuler, and G. J. Hammerling. 2005. Control of peripheral T-lymphocyte tolerance in neonates and adults. Trends Immunol. 26: 406-411.
65. Hartley, S. B., J. Crosbie, R. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353: 765-769.
66. Nemazee, D. A., and K. Burki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337: 562-566.
67. Akkaraju, S., K. Canaan, and C. C. Goodnow. 1997. Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J. Exp. Med. 186: 2005-2012.